MAPK3 and breast carcinoma: This modulatory effect of NPS-2143 treatment can be at least attributed to its effects on the major altered signaling pathways in breast cancer such as p-ERK1/2, integrin β1 and Bcl-2, which are all often altered in breast cancer.